459271.fig.002a
(a) CE81T/VGH cell
459271.fig.002b
(b) BE-3 cell
Figure 2: The morphology of esophageal cancer cells treated by Armillaridin. Cells were treated with a vehicle as control (left) or Armillaridin 10  M for 3 days (right). (a) CE81T/VGH squamous carcinoma cells. (b) BE-3 adenocarcinoma cells.